Download presentation
Presentation is loading. Please wait.
Published byFrancisca San Martín Montes Modified over 5 years ago
1
Volume 3, Issue 6, Pages 477-479 (November 2017)
Effective use of ustekinumab in a patient with concomitant psoriasis, vitiligo, and alopecia areata Amal Elkady, MBBCh, Lauren Bonomo, BA, Yasmin Amir, MD, Anjali S. Vekaria, MD, Emma Guttman-Yassky, MD, PhD JAAD Case Reports Volume 3, Issue 6, Pages (November 2017) DOI: /j.jdcr Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions
2
Fig 1 Patient at week 0 of ustekinumab therapy with depigmented macules on the back of scalp (A) compared to week 16 (B) of ustekinumab therapy with visible repigmentation surrounding the hair follicles. JAAD Case Reports 2017 3, DOI: ( /j.jdcr ) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions
3
Fig 2 Patient at week 0 of ustekinumab therapy with visible scattered alopecia patches and markedly decreased overall hair density (A) compared to week 20 (B) of ustekinumab therapy with visible regrowth and increased hair density. JAAD Case Reports 2017 3, DOI: ( /j.jdcr ) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.